X-Message-Number: 14012
From: "Mark Plus" <>
Subject: James Watson defends creating genetic superhumans.
Date: Wed, 28 Jun 2000 14:47:20 PDT

I (Mark Plus) found this on Salon's Website, 
http://www.salon.com/health/feature/2000/06/27/germline/index.html .

Salon.com health | Building better humans

      Building better humans
      The sci-fi possibilities of genetic tampering may soon become real. 
And
      there's no law against them.
      - - - - - - - - - - - -
      By Ralph Brave
      June 27, 2000 | A young couple having difficulty conceiving a child
      undergoes tests to pinpoint the problem. As they sit in the doctor's
      office, awaiting the results, each wonders whose reproductive system 
has
      failed.
      "There's nothing wrong with either of you," the doctor tells them, at
      last.



      "So what's the problem?" they ask.
      "You're two different species. You can't interbreed."
      Science fiction? Perhaps for now. But according to the eminent 
physicist
      Freeman Dyson, this is where the human genome project will inevitably 
lead
      us. He and his Princeton colleague, molecular biologist Lee Silver, 
say
      that rapidly emerging genetic technology will ultimately split 
humanity
      into many species.
      They draw their conclusion from cold, complex science, but their point 
is
      simple, and frightening: Once we figure out how to safely manipulate 
our
      genes, people will start adding and deleting them to their perceived
      advantage. Different sorts of humans will emerge. And it's safe to 
assume
      that each will decide that it is superior.
      While anyone who watched even a minute of "Britney in Hawaii" might
      believe that this has already occurred, rest assured it has not.
      But the development and use of genetic engineering are the subject of
      ferocious debate among the scientific elite. Some influential 
scientists,
      notably James D. Watson, the father of DNA research, are pushing for
      experiments that were once unthinkable: tampering with the human 
germline
      -- sperm and egg cells. In other words, genetically altering not only 
an
      individual, but future generations.
      "Some people are going to have to have some guts and try germline 
therapy
      without completely knowing that it's going to work," Watson said at a 
UCLA
      conference in 1998. "And the other thing, because no one has the guts 
to
      say it, if we could make better human beings by knowing how to add 
genes
      (from plants or animals), why shouldn't we do it? What's wrong with 
it?"
      Human germline engineering is prohibited in federally funded research. 
But
      there is no ban on such experiments in the private sector. Last 
weekend, a
      coalition of activists and organizations met in San Francisco to form 
the
      Exploratory Initiative on New Genetic Technologies. On Wednesday, the
      group will announce efforts to develop a broad movement to push for
      limitations on genetic technologies, including statutory bans on 
germline
      genetic engineering and human cloning.
      "A ban," says Watson, "would be a disaster."
      To get a glimpse of what might very well be our future, it helps to
      understand some boring science. All current human genetic therapy 
trials
      are called somatic: they involve genes in various parts of the body, 
but
      not the sex cells, which produce eggs and sperm. Tampering with sex 
cells
      -- producing genetic alterations that will be passed to your 
offspring,
      and their descendents -- takes genetic engineering into an entirely 
new
      technological and ethical realm.
      While many experts believe that germline engineering is at least a 
decade
      away, Hamilton Smith, a Nobel laureate biochemist, sees the technology
      developing much more rapidly. "It might come pretty quickly," he says.
      Smith knows something about the speed of technological advance. He is 
the
      director of DNA Resources for Celera Genomics Corp., which, in just 
nine
      months, produced a rough map of the human genome -- a feat that most
      scientists said would take years.
      The pressure for germline engineering is also likely to come from 
another
      direction -- you and me. We want children better than ourselves. We
      certainly don't want them to suffer unnecessarily. David Baltimore, a
      Nobel laureate who heads CalTech, believes that consumer demand will
      encourage the rapid development and utilization of germline 
engineering.
      Genetic screening is already standard in prenatal care. It is not
      farfetched to imagine that prospective parents will one day turn to
      clinics to produce embryos that can not only be tested for genetic
      defects, but also "corrected." And is there any reason to think people
      will stop at fixing disease-causing defects? Is it such a stretch to
      imagine people demanding genetic enhancements -- mental, physical,
      behavioral?
       Next page | Should humans take charge of their evolution?
      1, 2


Salon.com health | Building better humans




      Building better humans | 1, 2


      Prominent scientists not only believe the possibility is real; they 
are
      also preparing for it. At a retreat of the premier geneticists and 
policy
      analysts last summer at the Jackson Laboratory in Bar Harbor, Maine, 
LeRoy
      Walters, director of the Kennedy Center of Ethics, gave a speech on
      methods for guaranteeing equal access to the enhancement of 
intelligence.
      How close are we to being able to alter the human gene book? Germline
      genetic manipulation of other mammals is already occurring. Genes are
      routinely deleted from and added to mice for experiments. Five years 
ago a
      University of Pennsylvania researcher discovered how to alter the 
genes in
      the sperm of mice, and applied for a patent on it. In the wake of that
      advance, ethicists called for national and international meetings on
      germline engineering. Mice and humans are estimated to share 90 
percent of
      their genomes.






      The implications of germline engineering are so profound, and scary, 
that
      some leading scientists dismiss the possibility that anyone would
      seriously contemplate doing it. Asked Monday whether any reputable
      scientists are advocating germline engineering in humans, Celera 
founder
      and president J. Craig Venter said that he knew of nobody.
      But in a new book, Watson, perhaps the most influential figure in
      biological research in the last half-century, is quoted as calling for
      germline engineering during a 1998 conference at UCLA. Watson
      co-discovered the double helix structure of DNA, the basis for all the
      genetics research, including the mapping of the genome. He was the 
first
      director of the publicly funded Human Genome Project, and is now 
president
      of the Cold Spring Harbor Laboratory on Long Island. On July 4, he is
      scheduled to receive the $100,000 Liberty Medal in Philadelphia for 
his
      life's work.
      However shocking Watson's opinion might sound, he provides sound 
reasons
      for germline engineering, according to the transcript published in
      "Engineering the Human Germline: An Exploration of the Science and 
Ethics
      of Altering the Genes We Pass to our Children," edited by Gregory 
Stock
      and John Campbell. For one, germline engineering is more efficient 
than
      treating patients one by one. "You delete a bad gene from the gene 
pool,
      and no future generation need worry about it or undergo genetic 
therapy
      for it. Also, if a deadly infection broke out across the globe, 
humanity
      would be saved by implanting disease resistance into the germline."
      Watson offers scientists a strategy for confronting the social 
challenges
      that will face germline engineering.
      "I'm afraid of asking people what they think. Don't ask Congress to
      approve it. Just ask them for money to help their constituents. That's
      what they want ... Frankly they would care much more about having 
their
      relatives not sick than they do about ethics or principles."
      Although other nations, including Britain, Japan and China, cooperated 
in
      and contributed to the sequencing of the human genome, Watson believes
      that attempts to coordinate globally on the genome manipulation would
      retard the effort. "I think it would be a complete disaster to try and 
get
      an international agreement, he says. "I just can't imagine anything 
more
      stifling. You end up with the lowest common denominator."
      As for regulating genetic engineering, he says: "I think our hope is 
to
      stay away from regulations and laws whenever possible."
      Watson ridicules the notion that human genome has sanctity, or that 
civil
      rights should somehow enter the debate. "I think it's complete 
nonsense. I
      mean, what or who sanctifies? ... Evolution can just be damn cruel, 
and to
      say that we've got a perfect genome and there's some sanctity? ... 
Terms
      like sanctity remind me of animal rights. Who gave a dog a right? The 
word
      'rights' gets very dangerous. We have women's rights, children's 
rights;
      it goes on forever.
      "I'd like to give up saying rights or sanctity. Instead, say that 
humans
      have needs, and we should try as a social species to respond to those
      needs ... To try to give it more meaning than it deserves in some
      quasi-mystical way is for Steven Spielberg or somebody like that. It's
      just plain aura, up in the sky -- I mean, it's crap."
      Watson is not alone in his support for germline engineering. But in
      science circles there is also strong emerging opposition to such
      experiments, and growing support for regulation.
      Last month, Eric Lander, a friend of Watson and director of the 
largest
      publicly funded genome sequencing center, at the Massachusetts 
Institute
      of Technology, called for a ban on human germline gene therapy because 
of
      our limited knowledge. The human genome, Lander says, "has been 3.5
      billion years in the making. We've been able to read it for the last 
year
      or so. And we suddenly think we could write the story better?"
      Lander acknowledges that there are potential benefits to germline
      engineering. "There is the prospect that by changing things we might 
put
      off aging, prevent cancer, improve memory." The dazzling 
possibilities, he
      says, makes it tough to recommend reining in scientists. "I find it a 
very
      difficult question," he said. "For my own part, I would have a ban in
      place, an absolute ban in place on human germline gene therapy. Not
      because I think for sure we should never cross that threshold, but 
because
      I think that is such a fateful threshold to cross that I'd like 
society to
      have to rebut that presumption some day, to have to repeal a ban when 
it
      thought it was time to ever try something like that."
      Though Celera's Hamilton Smith and Lander were competitors in the race 
to
      complete the mapping of the human genome, they agree on this point. 
"The
      only thing I'm certain of is that we don't possess the knowledge to 
monkey
      with our germline," Smith says. "We don't fully understand the
      consequences of changes that even look like they would be good." As an
      example, Smith cites the single genetic mutation responsible for 
sickle
      cell disease, which has now been found to simultaneously provide
      resistance against malaria.
      Francis Collins, the director of the National Institutes of Health 
Human
      Genome Project, also has repeatedly urged caution on germline, which 
he
      views as humans fully taking charge of their evolution. But asked 
Monday
      whether he would support a ban, he demurred, afraid that opening that 
door
      for legislation could lead to other prohibitive measures that would 
impede
      important biomedical progress.
      Princeton's Dyson has his own ideas on what is to be done. In his 
view,
      the speciation of humans into different groups is inevitable -- and it
      would be a disaster to allow such diversification without restraint. 
"We
      must travel the high road into space, to find new worlds to match our 
new
      (genetic) capabilities," Dyson writes in "The Sun, The Genome and The
      Internet," published last year. "To give us room to explore the 
varieties
      of mind and body which our genome can evolve, one planet is not 
enough."
      More sci-fi fantasy? The ravings of an aging academic? I asked 
Celera's
      Smith what he thought. He paused, and then said, "Dyson's a very smart
      guy. I think there's a lot to what he says for the future. It's hard 
to
      tell where mankind is going here."

      salon.com | June 27, 2000
      - - - - - - - - - - - -
            About the writer
            Ralph Brave is a freelance writer living in Davis, Calif.
            Sound Off
            Send us a Letter to the Editor


            Salon.com >> Health











________________________________________________________________________
Get Your Private, Free E-mail from MSN Hotmail at http://www.hotmail.com

Rate This Message: http://www.cryonet.org/cgi-bin/rate.cgi?msg=14012